Edition:
United Kingdom

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

30.02USD
16 Jan 2018
Change (% chg)

$-1.98 (-6.19%)
Prev Close
$32.00
Open
$32.14
Day's High
$33.00
Day's Low
$29.05
Volume
576,175
Avg. Vol
391,254
52-wk High
$36.00
52-wk Low
$13.13

Select another date:

Fri, Dec 22 2017

BRIEF-Editas Medicine Files For Potential Stock Shelf, Size Undisclosed - SEC Filing

* EDITAS MEDICINE INC FILES FOR POTENTIAL STOCK SHELF, SIZE UNDISCLOSED - SEC FILING Source text: (http://bit.ly/2zhhSfB) Further company coverage:

BRIEF-Editas Medicine Announces Pricing Of $50 Mln Offering Of Common Stock

* EDITAS MEDICINE, INC., ANNOUNCES PRICING OF $50 MILLION OFFERING OF COMMON STOCK

BRIEF-Editas Medicine Announces Offering Of Common Stock

* EDITAS MEDICINE INC - INTENDS TO OFFER AND SELL $50 MILLION OF SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING Source text for Eikon: Further company coverage:

BRIEF-Editas Medicine announces Q3 loss per share $0.64

* Editas Medicine announces third quarter 2017 results and update

BRIEF-Editas receives EMA's orphan medicinal product designation for EDIT-101

* Editas Medicine receives EMA's orphan medicinal product designation for EDIT-101 for the treatment of LCA10

BRIEF-Editas Medicine Inc initiates clinical natural history study of Leber Congenital Amaurosis type 10

* Editas Medicine Inc - announced that company initiated a clinical natural history study of Leber Congenital Amaurosis type 10 (LCA10)

BRIEF-Editas Medicine Q2 loss per share $0.65

* Editas Medicine announces second quarter 2017 results and update

BRIEF-Editas Medicine achieves milestone under Juno Therapeutics collaboration

* Editas Medicine achieves milestone under Juno Therapeutics collaboration for technical progress towards overcoming the tumor microenvironment Source text for Eikon: Further company coverage:

Select another date: